Status:
COMPLETED
Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction
Lead Sponsor:
Emory University
Conditions:
Anterior Cruciate Ligament Rupture
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
This study will consist of 80 patients ages 18 to 50 at the Emory Orthopaedic and Spine Center who are undergoing Anterior Cruciate Ligament (ACL) reconstruction with a quadriceps tendon autograft or ...
Eligibility Criteria
Inclusion
- Ages between 18 and 50 chronological years undergoing ACL reconstruction using a quadriceps tendon or BTB autograft.
Exclusion
- Patients with known allergies to local anesthetics
- pregnant patients
- patients with a history of liver disease
- patients undergoing bilateral procedures
- Patients undergoing revision ACL surgery and patients undergoing ACL reconstruction using pediatric physeal sparing techniques
- Patients will also be excluded if any clinically significant event or condition is discovered during the time of, or after surgery that may render them medically unstable, or subject them to a surgical complication.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02189317
Start Date
August 1 2014
End Date
March 1 2015
Last Update
July 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Orthopaedic and Spine Center
Atlanta, Georgia, United States, 30324